Anthera Pharmaceuticals Accounts Payable:
5.206M for Dec. 31, 2012Anthera Pharmaceuticals Historical Accounts Payable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 5.206M |
| June 30, 2012 | 10.30M |
| March 31, 2012 | 13.85M |
| Dec. 31, 2011 | 17.43M |
| Sept. 30, 2011 | 17.48M |
| June 30, 2011 | 9.783M |
| March 31, 2011 | 7.664M |
| Dec. 31, 2010 | 3.791M |
| Sept. 30, 2010 | 2.798M |
| June 30, 2010 | 1.695M |
| March 31, 2010 | 3.330M |
| Dec. 31, 2009 | 3.146M |
| Sept. 30, 2009 | 2.561M |
| June 30, 2009 | 3.085M |
| Dec. 31, 2008 | 1.597M |
About Accounts Payable
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
For example, accounts payable increases when a company purchases inventory "on account." When the money is repaid, accounts payable decreases.
YCharts takes accounts payable numbers directly from balance sheet line items.
Learn More
ANTH Accounts Payable Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | |
| Pfizer | |
| Tetraphase Pharmaceuticals | 2.018M |
ANTH Accounts Payable Rankings
| Overall |
67th percentile 2579 of 8002 |
| Sector |
66th percentile 229 of 684 in Healthcare |
| Industry |
79th percentile 11 of 54 in Drug Manufacturers - Major |
ANTH Accounts Payable Range, Past 5 Years
| Minimum | 1.597M | Dec 2008 |
| Maximum | 17.48M | Sep 2011 |
| Average | 6.914M |
